I think you are misreading the comment you are replying to:
> Your comparison of your friends in Germany vs "insanity" in the US doesn't feel relevant
It's incredibly relevant, why are GLP-1s less needed in Germany vs. US (and other countries like Canada)? This is the insanity they are talking about, not the users of the medication.
> It's incredibly relevant, why are GLP-1s less needed in Germany vs. US
Aside from whether the local healthcare coverage will pay for it, and the rate of GLP1 usage probably being proportional to the obesity rate, what is the basis for assuming there is disproportionately fewer people in Germany using these medications? Most people don't announce it.
American here who lived in Germany for 3 years and now Scandinavia. Its what makes up the food. Most of the food served in America cant be served in the EU. Its straight up poison designed to make you addicted to it.
Couple that with a very car centric lifestyle and yea. Its not great.
If you look at the increase in overweight and obesity rates in Germany over the last 50 years, it’s clear that far more of the population “needs” GLP-1 than is using it. The rate of use will almost certainly increase dramatically.